Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam in Pediatric T2DM
NCT01258075Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 2011
- Primary completion
- Nov 2019
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of colesevelam in type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd.. Started Feb 2011; status: completed.
02
Drugs
colesevelam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01258075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01258075.